• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.28% Nasdaq Down 0.23%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    10.16 Down 0.24(2.31%) 2:24PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:10.40
    Open:10.34
    Bid:10.16 x 1500
    Ask:10.17 x 500
    1y Target Est:21.60
    Beta:5.19
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:10.07 - 10.37
    52wk Range:8.84 - 18.48
    Volume:392,856
    Avg Vol (3m):1,785,820
    Market Cap:1.05B
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    KERXDown 2.31%1.05B
    BAXUp 1.04%36.58B
    SHPGUp 0.86%51.12B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):538.70
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.91
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback